Reversible anti-settlement activity againstAmphibalanus(=Balanus)amphitrite, Bugula neritina, andHydroides elegansby a nontoxic pharmaceutical compound, mizolastine
- 24 July 2009
- journal article
- Published by Taylor & Francis in Biofouling
- Vol. 25 (8) , 739-747
Abstract
Mizolastine, an antihistamine pharmaceutical, was found to significantly inhibit larval settlement of the barnacle Amphibalanus (=Balanus) amphitrite, the bryozoan Bugula neritina, and the polychaete Hydroides elegans with EC(50) values of 4.2, 11.2, and 4.1 microg ml(-1), respectively. No toxicity against the larvae of these three species was observed at the concentration range tested during incubations with mizolastine. To determine whether the anti-settlement activity of mizolastine is reversible, recovery bioassays using these three species were conducted. More than 70% of the larvae that had been exposed for 4 h to mizolastine at concentrations four-fold greater than their respective EC(50) values completed normal metamorphosis. The results of the recovery bioassay provide evidence that the anti-settlement effect of mizolastine is reversible in addition to being nontoxic. The anti-settlement activities of several intermediates of the synthesis process of mizolastine were also examined. One of the intermediates, 2-chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole, inhibited larval settlement and metamorphosis with low toxicity. These results may improve the understanding of the key functional group responsible for the anti-settlement activity of mizolastine.Keywords
This publication has 38 references indexed in Scilit:
- Optimized maintenance and larval production of the bryozoan Bugula neritina (Bugulidae: Gymnolaemata) in the laboratoryAquaculture, 2007
- Fate of Irgarol 1051, diuron and their main metabolites in two UK marine systems after restrictions in antifouling paintsEnvironment International, 2007
- Antibacterial and antilarval activity of deep-sea bacteria from sediments of the West Pacific OceanBiofouling, 2007
- Influence of mizolastine on antigen-induced activation of signalling pathways in murine mast cellsClinical and Experimental Dermatology, 2006
- Remarkable Synergistic Effects in Antifouling Chemicals against Vibrio fischeri in a Bioluminescent AssayJournal of Health Science, 2006
- The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadineClinical and Experimental Dermatology, 2005
- Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastineAllergy, 2002
- Neurotransmitter blockers as antifoulants against planktonic larvae of the barnacleBalanus amphitriteand the musselMytilus galloprovincialisBiofouling, 1998
- Signal transduction in barnacle settlement: Calcium re‐visitedBiofouling, 1996
- New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-aminesJournal of Medicinal Chemistry, 1985